{"count": 3, "results": [{"_id": "35769369", "pmid": 35769369, "pmcid": "PMC9234123", "title": "Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis", "journal": "Front Neurol", "authors": ["Yu M", "Zheng X", "Cheng F", "Shao B", "Zhuge Q", "Jin K"], "date": "2022-06-13T00:00:00Z", "doi": "10.3389/fneur.2022.903565", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "903565", "score": 50254.105, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@Rapamycin@@@, or @CHEMICAL_Nicotinamide_Mononucleotide @CHEMICAL_MESH:D009537 @@@NMN@@@ Pretreatment Attenuates White Matter Lesions After @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@BCCAO@@@", "citations": {"NLM": "Yu M, Zheng X, Cheng F, Shao B, Zhuge Q, Jin K. Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis Front Neurol. 2022;13():903565. PMID: 35769369", "BibTeX": "@article{35769369, title={Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis}, author={Yu M and Zheng X and Cheng F and Shao B and Zhuge Q and Jin K}, journal={Front Neurol}, volume={13}, pages={903565}}"}}, {"_id": "26141671", "pmid": 26141671, "title": "Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction.", "journal": "Transl Res", "authors": ["Xu W", "Deng YY", "Yang L", "Zhao S", "Liu J", "Zhao Z", "Wang L", "Maharjan P", "Gao S", "Tian Y", "Zhuo X", "Zhao Y", "Zhou J", "Yuan Z", "Wu Y"], "date": "2015-11-01T00:00:00Z", "doi": "10.1016/j.trsl.2015.06.002", "meta_date_publication": "2015 Nov", "meta_volume": "166", "meta_issue": "5", "meta_pages": "451-8", "score": 50061.082, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates the proinflammatory state in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid artery atherosclerosis@@@ through @GENE_SIRT1 @GENE_23411 @@@sirtuin 1@@@ induction.", "citations": {"NLM": "Xu W, Deng YY, Yang L, Zhao S, Liu J, Zhao Z, Wang L, Maharjan P, Gao S, Tian Y, Zhuo X, Zhao Y, Zhou J, Yuan Z, Wu Y. Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. Transl Res. 2015 Nov;166(5):451-8. PMID: 26141671", "BibTeX": "@article{26141671, title={Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction.}, author={Xu W and Deng YY and Yang L and Zhao S and Liu J and Zhao Z and Wang L and Maharjan P and Gao S and Tian Y and Zhuo X and Zhao Y and Zhou J and Yuan Z and Wu Y}, journal={Transl Res}, volume={166}, number={5}, pages={451-8}}"}}, {"_id": "27862873", "pmid": 27862873, "title": "Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.", "journal": "Diabetes Obes Metab", "authors": ["Preiss D", "Dawed A", "Welsh P", "Heggie A", "Jones AG", "Dekker J", "Koivula R", "Hansen TH", "Stewart C", "Holman RR", "Franks PW", "Walker M", "Pearson ER", "Sattar N", "DIRECT consortium group"], "date": "2017-03-01T00:00:00Z", "doi": "10.1111/dom.12826", "meta_date_publication": "2017 Mar", "meta_volume": "19", "meta_issue": "3", "meta_pages": "356-363", "score": 50042.645, "text_hl": "AIMS: To investigate, in the @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@Carotid Atherosclerosis@@@: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin Resistance@@@ (CAMERA) trial (NCT00723307), whether the influence of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the @GENE_GLP1R @GENE_2740 @@@glucagon-like peptide (GLP)-1@@@ axis in individuals with and without @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ (T2DM) is sustained and related to changes in glycaemia or weight, and to investigate basal and post-meal @GENE_GLP1R @GENE_2740 @@@GLP-1@@@ levels in @SPECIES_9606 @@@patients@@@ with T2DM in the cross-sectional @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Research on @SPECIES_9606 @@@Patient@@@ Stratification (DIRECT) study. ", "citations": {"NLM": "Preiss D, Dawed A, Welsh P, Heggie A, Jones AG, Dekker J, Koivula R, Hansen TH, Stewart C, Holman RR, Franks PW, Walker M, Pearson ER, Sattar N, DIRECT consortium group. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes Obes Metab. 2017 Mar;19(3):356-363. PMID: 27862873", "BibTeX": "@article{27862873, title={Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.}, author={Preiss D and Dawed A and Welsh P and Heggie A and Jones AG and Dekker J and Koivula R and Hansen TH and Stewart C and Holman RR and Franks PW and Walker M and Pearson ER and Sattar N and DIRECT consortium group}, journal={Diabetes Obes Metab}, volume={19}, number={3}, pages={356-363}}"}}]}